share_log
Reuters ·  Mar 21 10:09
Enliven Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $39 From $37
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 367

Recommended

Write a comment